Skip to content

ESD Home

TechCentury

Powered by

Engineering Society of Detroit Lawrence Technological University

Tag: Esperion Therapeutics Inc.

Pharmaceuticals

Esperion cholesterol-buster gets European OK

ANN ARBOR—The European Commission has approved the sale of new cholesterol-lowering drugs from Ann Arbor-based Esperion Therapeutics Inc. (Nasdaq: ESPR). Approved were Nilemdo, a tablet containing the new drug bempedoic …

Finance / Pharmaceuticals

Esperion Announces Public Offering of Common Stock

ANN ARBOR — The cholesterol-fighting drug developer Esperion Therapeutics Inc. (NASDAQ:ESPR) Tuesday announced the proposed sale of $150 million of its common stock in an underwritten public offering. Esperion also …

Read the magazine:

TechCentury
Advertise or Contribute an Article

Subscribe to TechCentury.com

Top Posts

  • Our Next Energy raises $300 million in Series B
  • Full STEM ahead: Oakland Schools show off new mobile classroom
  • New LTU-EGLE program taps retired professionals' skills to boost sustainability
  • AdAdapted names senior VP of marketing
  • Teams from Rochester, Ann Arbor headed to Future City finals in DC

Archives

Follow Us On

© The Engineering Society of Detroit   |   ABOUT